VS-7375, an oral KRAS G12D inhibitor, received FDA clearance for clinical trials in advanced solid tumors, including pancreatic, colorectal, and non-small cell lung cancers. Verastem Oncology will ...
“The broad capabilities of the OncoExTra assay detected therapeutically actionable and other clinically relevant genomic events that can inform clinical decision-making for patients with advanced ...
Patient-generated health DATA as a risk stratification tool: Real-world multidisciplinary care study from a developing-country private clinic. Influence of unruptured abdominal aortic aneurysm (AAA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results